In 2019, the United States dominated the automated cell culture market, holding a substantial market share of 85.74%, valued at USD 404.8 million. The market is anticipated to maintain a robust growth trajectory with a projected Compound Annual Growth Rate (CAGR) of 13.08% during the forecast period. Meanwhile, Canada's market, valued at USD 67.3 million in 2019, is expected to witness a higher CAGR of 13.77%.
The modular automation segment played a pivotal role, capturing the majority of the market at 66.46% in 2019, with a market value of USD 313.8 million. This segment is poised for continued growth, expected to register a higher CAGR of 13.35% during the forecast period. In comparison, the whole lab automation segment, valued at USD 158.4 million in 2019, is projected to exhibit a CAGR of 12.83%.
Among equipment types, the automated liquid handling systems segment emerged as the market leader in 2019, commanding a share of 32.10% and a market value of USD 151.5 million. This segment is forecasted to sustain growth with an expected CAGR of 13.04%. The microplate readers segment, valued at USD 125.2 million in 2019, is projected to exhibit a CAGR of 13.34%. Notably, the automated storage & retrieval systems (ASRS) segment is anticipated to register the highest CAGR of 13.83%.
In terms of applications, the biopharmaceutical production segment claimed the largest market share at 22.04% in 2019, amounting to USD 104.1 million. This segment is projected to maintain a steady CAGR of 13.34% during the forecast period. The tissue engineering & regenerative medicine segment, valued at USD 81.9 million in 2019, is expected to exhibit a CAGR of 13.06%. On the other hand, the drug screening and development segment is anticipated to witness the highest CAGR of 13.83%.
In the end-user segment, pharmaceutical & biotechnology companies held the lion's share at 37.67% in 2019, with a market value of USD 177.8 million. This segment is poised for substantial growth, projected to register the highest CAGR of 13.93% during the forecast period. The research institutes segment, valued at USD 154.2 million in 2019, is expected to exhibit a CAGR of 12.84%.
Once again, within the modular automation segment, the market leader held a share of 66.31% in 2019, with a value of USD 268.5 million. This segment is expected to continue its dominance, registering a higher CAGR of 13.25% during the forecast period. Meanwhile, the whole lab automation segment, valued at USD 136.4 million in 2019, is projected to exhibit a CAGR of 12.73%.
Conclusively, the automated cell culture market's dynamic growth is evident across various segments, reflecting the industry's robust prospects and technological advancements.
